Next PCSO meeting 10 October 2023 - Guest Speaker Richard Wassersug, PhD

Our next regular monthly PCSO meeting will be on 10 October 2023, in-person at the Maplesoft-Jones Centre [MAP] and online virtually on ZOOM, starting at 6:30 pm. Our guest speaker will be Richard Wassersug, PhD, and his topic will be ADT & Me - With Some Asides On Other Topics that Should Interest Most Every Prostate Cancer Patient.

Dr. Wassersug is Canada’s leading expert on the impact of ADT on prostate cancer patients, and Co-lead of the highly successful Life on ADT Educational Program in Canada, featured on the Resources page of the PCSO website. He plans to keep his prepared remarks brief, so that plenty of time will be available to share our ADT experiences with him and with each other. This will be a PCSO guest speaker event you won’t want to miss!

To attend in person at the Maplesoft-Jones Centre

- Please register early at .(JavaScript must be enabled to view this email address), and make sure to include the number of attendees in your party.
- By email, we’ll either confirm your reservation, or advise you that we’ve reached the Centre’s capacity of 24 persons.

Note: Masks are not mandatory but are recommended in the Maplesoft-Jones Centre

To attend virtually by Zoom

- Please register at the following link - https://us06web.zoom.us/meeting/register/tZMvdO6vpj8iHtwAzUEUyjoalKM0S77MUhqY.

- After registering, you’ll receive an email with instructions on joining the meeting.

Portrait of Dr. Richard WassersugDr. Richard Wassersug, PhD, is a retired Professor of Anatomy and Neurobiology from Dalhousie University in Halifax Nova Scotia, and now holds the title of “Honorary Professor” in the Faculty of Medicine at the University of British Columbia. Richard is the lead author of the book Androgen Deprivation Therapy: An Essential Guide for Prostate Cancer Patients and Their Loved Ones, which came out as a third edition in the spring of this year. He is also the Co-lead for the national Androgen Deprivation Therapy (ADT) Educational Program in Canada.

ADT (commonly called hormone therapy) is the standard treatment for systemic prostate cancer. A major focus of Richard’s research is on developing ways to help men and their partners manage the side effects of ADT. Richard will be talking about his personal experience as a patient on ADT. He plans to tell us how that evolved into a research career on the psychological impact of androgen deprivation for populations ranging from prostate cancer patients to transgender individuals on hormone therapy.

Richard has been on various forms of ADT almost continuously for over 20 years and has authored or co-authored over 40 papers in the peer-reviewed medical literature related to testosterone. He has also published several personal essays on his experience with ADT. His talk will integrate his personal story with his research and the supportive care initiatives that he has helped develop for other prostate cancer patients.

Regular PCS Ottawa Meetings

Unless otherwise noted, we hold Prostate Cancer Support Ottawa’s regular monthly meetings at the Maplesoft-Jones Cancer Survivorship Centre [Map] on the third Thursday of each month. We don’t hold meetings in the months of July and August, except for our ever-popular annual BBQ on the third Thursday of August.

We offer most of our meetings in hybrid format, allowing you to attend either in person or virtually. Watch our Meetings and Events website page or your e-mail inbox for meeting locations and specific registration instructions.

We normally start our meetings with a social gathering at 6:30 pm, followed at 7:00 pm with brief business announcements, followed by either a guest speaker or a sharing session.

We thank you for your continued support!

CanadaHelps

Not sure where to start?

We are only a phone call or email away. Contact PCSO anytime at 613-828-0762 or .(JavaScript must be enabled to view this email address).

Donate

You can help support men and their families affected by prostate cancer.

How to give

< Back to meetings and events page.